Home › Stocks › ENTA › All Fund Holders
ENTA — ENANTA PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $243.54M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 3.78M | $47.72M | 0.02% | Add |
| BlackRock Inc history | Q2 2026 | 3.24M | $47.30M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 2.30M | $36.30M | 0.00% | Add |
| Farallon Capital Management history | Q2 2026 | 2.42M | $35.26M | 0.16% | Reduce |
| Geode Capital Management history | Q2 2026 | 776.63K | $11.33M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 643.97K | $9.39M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 557.60K | $8.13M | 0.01% | Reduce |
| Point72 Asset Management history | Q4 2025 | 438.94K | $6.92M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 464.65K | $6.77M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 315.73K | $4.60M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 301.15K | $4.39M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 259.70K | $3.79M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 256.87K | $3.75M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2023 | 115.49K | $2.47M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 132.00K | $1.92M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 96.76K | $1.40M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 81.63K | $1.19M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 76.76K | $1.12M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 71.16K | $1.04M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 64.32K | $937.77K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 59.53K | $867.95K | 0.00% | Reduce |
| Arrowstreet Capital history | Q4 2025 | 52.73K | $831.52K | 0.00% | New |
| PSP Investments history | Q2 2023 | 35.13K | $751.80K | 0.01% | Add |
| Manulife Financial history | Q1 2023 | 17.97K | $726.54K | 0.00% | Hold |
| Franklin Resources history | Q2 2026 | 48.52K | $707.39K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 39.87K | $581.23K | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 34.54K | $503.58K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 29.50K | $430.19K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 27.95K | $407.53K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 26.20K | $382.00K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 24.93K | $363.55K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 21.54K | $314.00K | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2024 | 40.70K | $234.03K | 0.00% | Hold |
| Balyasny Asset Management history | Q2 2026 | 14.91K | $217.46K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 13.88K | $202.34K | 0.00% | Add |
| CPP Investments history | Q4 2025 | 8.90K | $140.35K | 0.00% | New |
| Lazard Asset Management history | Q3 2021 | 1.15K | $65.00K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 2.81K | $40.97K | 0.00% | Add |
| Amundi US history | Q3 2023 | 1.98K | $19.09K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 360 | $14.56K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 556 | $8.11K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 23.30K | $340 | 0.00% | Add |